David G. Pfister
- Otorhinolaryngology top 0.01%
- Head and Neck Cancer Studies 144
- Oncology top 0.1%
- Cancer Diagnosis and Treatment 33
- Lung Cancer Research Studies 22
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 43
- Lung Cancer Diagnosis and Treatment 20
- Surgery top 0.2%
- Head and Neck Surgical Oncology 48
- Salivary Gland Tumors Diagnosis and Treatment 28
- Cancer Research top 0.5%
-
- Thyroid Cancer Diagnosis and Treatment 31
- Co-authors
- Dennis H. KrausJatin P. ShahNancy Y. LeeEric J. ShermanSuzanne L. WoldenMichael J. ZeléfskyMatthew G. FuryMark R. Somerfield
- Journals
- New England Journal of Medicine (2 papers)JAMA (1 paper)Journal of Clinical Oncology (115 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
David G. Pfister
312 papers receiving 18.8k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Otorhinolaryngology 5.7k
- Oncology 8.9k
- Pulmonary and Respiratory Medicine 7.2k
- Surgery 5.9k
- Cancer Research 1.9k
Countries citing papers authored by David G. Pfister
This map shows the geographic impact of David G. Pfister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Pfister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Pfister more than expected).
Fields of papers citing papers by David G. Pfister
This network shows the impact of papers produced by David G. Pfister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Pfister. The network helps show where David G. Pfister may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David G. Pfister, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 0 | |
| 13 | Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinomabreakdown → | 2020 | 264 |
| 14 | 2020 | 12 | |
| 15 | 2018 | 64 | |
| 16 | Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Studybreakdown → | 2017 | 497 |
| 17 | 2017 | 6 | |
| 18 | 2010 | 380 | |
| 19 | 2010 | 136 | |
| 20 | American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancerbreakdown → | 2009 | 752 |
About David G. Pfister
David G. Pfister is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 328 papers that have together received 19.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (144 papers), Head and Neck Surgical Oncology (48 papers), Lung Cancer Treatments and Mutations (43 papers), Cancer Diagnosis and Treatment (33 papers), Thyroid Cancer Diagnosis and Treatment (31 papers), Salivary Gland Tumors Diagnosis and Treatment (28 papers), Lung Cancer Research Studies (22 papers) and Lung Cancer Diagnosis and Treatment (20 papers). The work is most often cited by research in Otorhinolaryngology (5.7k citations), Oncology (8.9k citations) and Pulmonary and Respiratory Medicine (7.2k citations). David G. Pfister has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Dennis H. Kraus, Jatin P. Shah, Nancy Y. Lee, Eric J. Sherman, Suzanne L. Wolden, Michael J. Zeléfsky, Matthew G. Fury, Mark R. Somerfield, Ashok R. Shaha and Alan L. Ho. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.